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Abstract
Introduction Controversy exists over the preferred technique of preoperative biliary drainage (PBD) in patients with hilar
cholangiocarcinoma (HCCA) requiring major liver resection. The current study compared outcomes of endoscopic biliary
drainage (EBD) and percutaneous transhepatic biliary drainage (PTBD) in patients with resectable HCCA.
Methods One hundred fifteen consecutive patients were explored for HCCA between 2001 and July 2008 and assigned by
initial PBD procedure to either EBD or PTBD.
Results Of these patients, 101 (88%) underwent PBD; 90 patients underwent EBD as primary procedure, and 11 PTBD. The
technical success rate of initial drainage was 81% in the EBD versus 100% in the PTBD group (P=0.20). Stent dislocation
was similar in the EBD and PTBD groups (23% vs. 20%, P=0.70). Infectious complications were significantly more
common in the endoscopic group (48% vs. 9%, P<0.05). Patients in the EBD group underwent more drainage procedures
(2.8 vs. 1.4, P<0.01) and had a significantly longer drainage period until laparotomy (mean 15 weeks vs. 11 weeks in the
PTBD group; P<0.05). In 30 patients, EBD was converted to PTBD due to failure of the endoscopic approach.
Conclusions Preoperative percutaneous drainage could outperform endoscopic stent placement in patients with resectable
HCCA, showing fewer infectious complications, using less procedures.
Keywords Endoscopic.Percutaneous.Biliarydrainage.
Cholangiocarcinoma.Preoperative
Introduction
Hilar cholangiocarcinoma (HCCA) remains one of the most
difficult tumors in terms of staging and radical surgical
treatment.
1 The optimal mode of preoperative management
is still under debate. Most patients with HCCA show liver
dysfunction caused by obstructive jaundice, which has
proven to be a significant risk factor in major liver
resection.
2–4 A potentially fatal complication of extended
liver resection in a jaundiced patient is failure of the
remnant liver. Therefore, preoperative biliary drainage
(PBD) has been devised for jaundiced patients undergoing
major hepatic resection to improve the surgical outcome.
5,6
Controversy exists regarding the preferred technique of
PBD, either via endoscopic retrograde biliary drainage
(EBD) or using antegrade percutaneous transhepatic biliary
drainage (PTBD). PTBD is the preferred method in Japan
for relief of obstructive jaundice due to proximal obstruc-
tion.
7,8 In Europe and the USA, EBD is usually performed
as primary intervention and is followed by PTBD only
This work was presented at the Digestive Disease Week, 01-06-2009,
Chicago.
Support: there have not been any sources of outside support for this
research.
J. J. Kloek: N. A. van der Gaag: Y. Aziz:O. R. C. Busch:
D. J. Gouma:T. M. van Gulik (*)
Department of Surgery, Academic Medical Center,
University of Amsterdam,
P. O. Box 22700, 1100 DE, Amsterdam, The Netherlands
e-mail: t.m.vangulik@amc.uva.nl
E. A. J. Rauws
Department of Gastroenterology, Academic Medical Center,
University of Amsterdam,
Amsterdam, The Netherlands
O. M. van Delden: J. S. Lameris
Department of Radiology, Academic Medical Center,
University of Amsterdam,
Amsterdam, The Netherlands
J Gastrointest Surg (2010) 14:119–125
DOI 10.1007/s11605-009-1009-1when EBD has failed. Internal drainage by EBD, although a
less invasive technique, carries increased risk of developing
cholangitis due to bacterial contamination from the duode-
num and increased risk of procedure-related complications
such as duodenal perforation and post-EBD, acute pancre-
atitis.
9,10 Drainage by means of PTBD is associated with
hemobilia, portal vein thrombosis, cancer seeding, and
potentially more patient discomfort.
11–13
The three published prospective randomized controlled
trials comparing EBD versus PTBD, included patients with
unresectable bile duct tumors or carcinoma of the gallblad-
der and pancreas showing conflicting results.
14–16 These
studies address palliative treatment and, although important
in the context of biliary drainage no, distinction was made
between distal and proximal bile duct obstruction. In
patients with HCCA with usually involvement of the
segmental biliary ducts, drainage of the intrahepatic biliary
tree is challenging and mostly requires multiple drains or
stents. However, in patients with a distal bile duct
obstruction, usually caused by a tumor in the region of
the pancreatic head, drainage is more straightforward and
requires a single drain or stent. In the latter category of
jaundiced patients in whom partial liver resection is usually
not undertaken, PBD remains a controversial issue.
17,18
To date, no studies have been performed regarding the
optimal route of drainage in patients with a potentially
resectable HCCA. Therefore, the aim of the present study
was to compare success rate and complications of EBD and
PTBD in patients eligible for resection of a suspected
HCCA.
Materials and Methods
Patients
A total of 115 patients underwent an explorative laparoto-
my under the suspicion of HCCA between January 2001
and July 2008, of which 101 (88%) underwent PBD and
were included in the present study (Fig. 1). Fourteen
patients did not undergo drainage as their bilirubin level
did not exceed 40 µmol/L. Usually, resectional surgery was
performed when serum bilirubin levels had decreased to
≤40 µmol/L. When feasible, hilar resection with complete
lymphadenectomy of the hepatoduodenal ligament was
performed, usually en bloc with (extended) hemihepatec-
tomy, caudate lobe resection and the portal vein bifurcation
when involved by tumor.
19 Unresectable disease, due to
vascular ingrowth and/or (extra) hepatic metastases, was
confirmed histologically. Patients were divided into two
groups according to the primary drainage procedure; PTBD
or EBD. In the majority of the included patients, the initial
diagnostic evaluation and drainage procedures were per-
formed in the referring hospitals. Medical data of patients
collected from these hospitals and from our tertiary
referring center included demographic features, laboratory
investigations, results of imaging studies, results of EBD
and PTBD, and intra-operative findings.
Staging of HCCA
Proximal obstruction in the biliary tract was staged
according to the Bismuth–Corlette classification based on
all available imaging studies.
20 Bismuth type I and II
tumors obstruct the proximal common hepatic duct or
hepatic duct confluence, but do not extend into the
intrahepatic segmental ducts; Type IIIa/b tumors involve
the hepatic duct confluence and extend into the right or left
segmental intrahepatic branches; Type IV tumors involve
the hepatic duct confluence with extension into both the
right and left segmental branches.
Biliary Decompression
The technique of PTBD in this series involves the use of
ultrasound guidance, a thin Chiba needle and a 0.014-in.
guidewire to gain access to the biliary system. Antegrade
cholangiography was performed to localize the site of
obstruction, after which the guidewire was advanced through
the stenosis. Thereafter, a catheter was placed with its distal
end in the duodenum for internal–external drainage. The bile
was collected for the first 48 h, after which the catheter was
closed in order to achieve internal drainage.
Figure 1 Flow chart of patients eligible for resection of hilar
cholangiocarcinoma (HCCA) in the period from January 2001 to July
2008.
120 J Gastrointest Surg (2010) 14:119–125For EBD, straight Amsterdam type polyethylene stents
were used.
21 After a small sphincterotomy to facilitate
introduction of the various catheters a retrograde cholan-
giography was performed to localize the site of obstruc-
tion. The guidewire was maneuvered through and above
the biliary stenosis followed by a catheter. The endopros-
thesis was then pushed in position over the catheter. The
guidewire, catheter, and endoscope were removed, leaving
the polyethylene stent in situ. When insertion of two stents
was required during the same session, two guidewires
were placed before insertion of the first stent. Radiological
imaging was not part of routine drainage procedure
planning.
Definition of Events
Technical success was defined as stent/catheter insertion
across the stricture with appropriate position and imme-
diate biliary decompression. Infectious complications
comprised cholangitis and/or cholecystitis. Cholangitis
was defined as a temperature >38.5°C without another
demonstrable cause that persisted for longer than 24 h,
together with biochemical evidence of cholestasis and
infection (increased C-reactive protein and leucocytes).
Cholecystitis was diagnosed on the basis of right upper
quadrant pain, along with supportive evidence on
imaging studies. Acute pancreatitis was defined as
persistent abdominal pain with three times or more
elevation of serum amylase levels.
10 Stent dysfunction
(occlusion, migration, or failure) was scored when
persistence or recurrence of jaundice was determined
and/or imaging studies showed evidence of dilated
segmental biliary ducts. Biliary re-intervention was de-
fined as any type of endoscopic or percutaneous procedure
that was required to improve biliary drainage after stent
insertion. Finally, therapeutic success was defined when
an almost normal range bilirubin level (≤40 µmol/L) was
achieved at the time of last plasma bilirubin measurement
before surgery. All abovementioned events were taken
into account during the period from the first attempt of
drainage until explorative laparotomy.
Intention to Treat Analysis
We assessed the effect of the biliary drainage procedures
using the following variables: technical success of stent
insertion, infectious complications, stent migration, num-
ber of procedures, interval from first drainage attempt
until explorative laparotomy, and therapeutic success. For
the intention-to-treat analysis, we assigned subjects by
initial drainage procedure (n=101) to the EBD group or
PTBD group. The EBD group included also patients in
whom EBD was finally converted to PTBD, because of
technical failure (including no drainage of the future
remnant liver) and/or recurrence of complications.
Statistics
Statistical analysis was performed using the Statistical
Package for Social Sciences 14.0 (SPSS, Chicago, Illinois,
USA). Mean±SD, or median with range if not normally
distributed, described continuous parameters. Student’s t
test, Mann–Whitney U test, or Fisher’s exact test were used
where appropriate, analyzing the differences in the various
parameters between groups. A P value of <0.05 was
considered statistically significant.
Results
Patient Characteristics
Table 1 shows the baseline characteristics of 101 patients
undergoing PBD: 90 patients underwent EBD as primary
procedure and 11 patients PTBD. The median age, male–
female ratio, and the extent of bile duct involvement
classified according to the Bismuth staging system did
not differ significantly between groups. No differences
were observed in plasma bilirubin levels before drainage.
The diagnosis as confirmed by histopathological assess-
ment of the resection specimen or of biopsies in the non-
resected patients was equally distributed between the
EBD and PTBD group. There was a difference between
both groups in the type of hospital where the initial
drainage procedure was undertaken. In the PTBD group
more initial procedures (6/11) were performed in a
tertiary care center (P=0.01). Surgical outcome was not
different between both groups in terms of morbidity and
mortality (data not shown).
Technical and Therapeutic Success
Initial drainage was technically successful in 73 (81%)
patients in the EBD versus 11 (100%) patients in the
PTBD group (P=0.203, Table 2). In all patients in the
PTBD group, internal biliary drainage was achieved by
passing the catheter across the tumor site, into the
duodenum. With regard to the 17 patients in the
endoscopic group in whom the initial procedure failed,
this was due to patient agitation (n=2), procedure-related
complications (n=2, severe sphincterotomy bleeding and
duodenal perforation, respectively) and difficulties in
passing the stricture (n=13). In eight of these 17 patients,
endoscopic stent placement succeeded at a subsequent
attempt. The other nine patients were either directly
switched to PTBD or after failure of subsequent endo-
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other than failure of drainage, were bile duct perforation in
one patient in the EBD group and hemobilia in the PTBD
group. The mean number of drains/stents in situ before
surgery to achieve sufficient drainage of at least the future
remnant liver was 1.4 (range 1–3) in the PTBD group and
1.7 (1–4) in the endoscopic group (P=0.134). Therapeutic
success was equally effective since the plasma bilirubin
levels before laparotomy were similar in both groups
(Table 2).
Complications
The distribution of complications in both groups is
s h o w ni nT a b l e2. The most frequent complication was
cholangitis which occurred significantly more often in the
EBD group. Forty-eight percent of the patients in the EBD
group had one or more infectious complications compared
to 9% in the PTBD group (P=0.021). Another infectious
complication was acute cholecystitis which occurred in
one patient of the EBD group. This patient was treated
successfully by percutaneous drainage of the gallbladder
until laparotomy. Although the rate of one or more stent
dislocations per patient was similar in the EBD and PTBD
groups (23% vs. 20%, P=0.701), the number of re-
interventions required to manage infectious and stent-
related problems was significantly increased in the EBD
group compared to the PTBD group (2.8 vs. 1.4, P<0.01).
The increased number of infectious complications in the
EBD group resulted in a longer mean drainage period until
explorative laparotomy, namely 15 weeks (min–max 4–
29) in comparison to 11 weeks (3–21) in the PTBD group
(P=0.033). Furthermore, other complications were
recorded such as acute pancreatitis (n=7), hemobilia
(n=1), and biliary perforation (n=1). Pancreatitis was
only observed in the EBD group. In one patient after an
endoscopic procedure, a bile duct perforation resulted in
severe peritonitis, sepsis, and admission to the intensive
PTBD (n=11) EBD (n=90) P value
a
Gender male–female 6–56 4 –26 0.305
Median age (range) 61 (36–75) 61 (37–77) 0.870
Mean plasma bilirubin pre drainage 231 (±140) 177 (±112) 0.231
Bismuth classification 0.837
Type I, II 3 (27%) 22 (25%)
Type III, IV 8 (73%) 68 (75%)
Final pathological diagnosis 0.237
Cholangiocarcinoma 8 (73%) 80 (89%)
Metastatic disease – 1 (1%)
Benign stricture 3 (27%) 9 (10%)
Initial procedure tertiary—referring hospital 6–51 6 –74 0.012
Table 1 Characteristics of 101
Patients Undergoing PBD
Suspicious of Resectable HCCA
PBD preoperative biliary drain-
age, EBD endoscopic biliary
drainage, PTBD percutaneous
transhepatic biliary drainage
aP value is PTBD vs. EBD
(Fisher’s exact test or Mann–
Whitney U test)
PTBD (n=11) EBD (n=90) P value
a
Technical success stent insertion 11 (100%) 73 (81%) 0.203
Complications
Infectious 1 (9%) 43 (48%) 0.021
Cholangitis 1 43
Acute cholecystitis – 1
Dislocation 2 (20%) 21 (23%) 0.701
Other
Pancreatitis – 7
Hemobilia 1 –
Duodenal perforation – 1
Biliary perforation – 1
Wks drainage → laparotomy (range) 11 (3–21) 15 (4–29) 0.033
Mean no. of procedures (range) 1.4 (1–3) 2.8 (1–7) 0.001
Mean no. of stents in situ (range) 1.4 (1–3) 1.7 (1–4) 0.134
Mean plasma bilirubin pre-laparotomy 18 (±14) 23 (±21) 0.995
Table 2 Clinical Outcome of
Patients After PBD via the
Endoscopic or Percutaneous
Approach
EBD endoscopic biliary drain-
age, PTBD percutaneous trans-
hepatic biliary drainage
aP value is PTBD vs. EBD
(Fisher’s exact test or Mann–
Whitney U test)
122 J Gastrointest Surg (2010) 14:119–125care unit. Transient hemobilia occurred in one patient in
the PTBD group, but required no blood transfusion.
Patients Treated with Both Procedures
The EBD group included patients in whom the endoscopic
interventions were finally converted to PTBD. In total 30
patients were switched including the nine abovementioned
patients in whom initial endoscopic drainage had failed.
Conversion to PTBD was mainly due to recurrence of
complications and in three patients (10%) because the
endoscopic approach had failed to drain the future remnant
liver. In 10 (33%) patients in whom endoscopic stent
placement was eventually converted to the percutaneous
approach, one single PTBD procedure sufficed until
explorative laparotomy. One severe complication occurred
after a PTBD procedure, namely portal vein thrombosis
which rendered the patient unresectable as determined
during explorative laparotomy. The rate of infectious
complications in patients with mixed procedures was
67%. Sixteen (53%) of the 30 switched patients had one
or more stent dislocations, resulting in a mean number of
4.2 (range 2–7) procedures per patient. Finally, the mean
drainage period until explorative laparotomy was 15 weeks
(min–max 5–26 weeks). The number of stent dislocations
in the switched group comprised the sum of endoscopic and
percutaneous migrated stents, whereas in the analysis of the
EBD group (the abovementioned 90 patients) only the
endoscopic-migrated stents were included. Concerning
infectious complications no distinction was made because
after a mix of different approaches it is difficult to assess
which procedure initially caused the infection.
Discussion
The results of the present study show a more favorable
outcome of PTBD than of EBD for PBD in patients with
potentially resectable HCCA. EBD is associated with more
infectious complications resulting in a higher number of
procedures and finally a longer work-up period until
explorative laparotomy. We are aware of the limitations of
the present study; a retrospective analysis and unequal
distribution of patient number in the treatment groups.
However, to our knowledge, no other studies are available
comparing endoscopic with percutaneous biliary drainage
in patients with potentially resectable HCCA. As in the
earlier mentioned prospective trials,
14–16 the results of a
recently published retrospective study about this issue was
in the setting of palliative treatment.
22
In the diagnostic strategy of hilar lesions accuracy of
computed tomography or magnetic resonance cholangiog-
raphy is known to be higher when performed prior to stent
placement, due to prevention of endoprosthesis scattering
artifacts. Correct staging according to the Bismuth classi-
fication has shortcomings for determining resectability of
tumors,
23 but is useful in deciding a proper biliary drainage
strategy, i.e. the future liver remnant. Moreover, this highly
improves the success of subsequent stent placement.
24,25
Interventional radiologists are more likely to perform pre-
procedural imaging themselves and therefore, benefit from
this information. Although considered an obsolete proce-
dure for diagnostic purposes, endoscopic retrograde chol-
angiography is nevertheless still regularly performed before
radiological imaging in the evaluation of obstructive
jaundice. This might at least in part explain the high
number of EBD procedures used as initial mode in this
series.
Tumors of the proximal bile ducts are rare and the
varying experience of the endoscopist during the initial
drainage procedure could have biased the outcome of this
study. Most initial procedures in the PTBD group were
performed in a tertiary referring center (i.e. AMC) with
consequently, greater case load and experienced interven-
tional radiologists. A number of surgical studies have
shown a relationship between procedural volumes of an
institution and patient outcomes.
26,27 This relationship has
been most consistent for complex procedures and along the
same lines, seems to hold true on the level of interventions
for biliary drainage,
28 especially in cases of hilar bile duct
tumors.
Cholangitis due to bacterial contamination originating
from the duodenum is a serious clinical problem which
often requires additional interventions. Cholangitis after
PTBD is also possible especially when extended to internal
drainage. A 48% infectious complication rate after EBD is
comparable with other series in the literature,
9,29 albeit
drawing a parallel between these studies is difficult
depending on applied definitions of infectious complica-
tions. A 9% infectious rate after PTBD is low and could be
biased by the small number of patients included in this
group although comparable rates have been described after
PTBD in larger series in the literature.
30 Acute pancreatitis,
however uncommon, is a potentially severe complication
which was only observed in the EBD group. The increased
infection rate probably explains the significantly higher
number of necessary re-interventions in the EBD group in
comparison to the PTBD group.
Stent migration is another important complication
requiring re-intervention. With self-expanding metal stents,
dislodgement of the stent is exceptional,
31 but its use is
generally confined to unresectable disease. In the present
study, polyethylene endoprostheses were used because
patients were all potentially resectable. Stent dislodgement
in the endoscopic and percutaneous group occurred around
20%, which is rather high in comparison to other
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32,33 Apart from the high migration incidence we
can conclude that the approach, either by EBD or by
PTBD, had no influence on stent patency.
Which part of the liver should be drained is an ongoing
controversy.
12,32 Pre-procedural planning should involve
evaluation of the exact level and extension of the stricture
site, selection of the most appropriate liver segments for
drainage and assessment of an appropriate access route.
PTBD offers the possibility to perform selective biliary
drainage (SBD) whereas EBD via both the left and right
hepatic duct often implies total biliary drainage (TBD). An
argument for SBD of the future remnant liver is the
subsequent induction of hypertrophy on this side of the
liver, and atrophy of the non-drained part of the liver to be
resected.
34,35 In a retrospective cohort study in which the
effect of SBD versus TBD was investigated before
hepatectomy in 42 patients, SBD was not found to increase
the risk of cholangitis.
36 In association with portal vein
embolization, SBD proved superior to TBD in promoting
hypertrophy of the future remnant liver, by which extended
hemihepatectomy could be performed more safely. The
only existing prospective randomized controlled trial
comparing TBD versus SBD included patients with
unresectable hilar bile duct tumors.
37 Unilateral drainage
resulted in a higher technical success rate of stent insertion
and a significantly lower incidence of complications. The
above studies showed better results for SBD and therefore
indirectly indicated a preference for PTBD through which
segmental drainage is more easily achieved.
In our study we did not evaluate the cost-effectiveness of
both procedures. From other studies in literature it is known
that the number of re-interventions is an important factor
influencing the final costs. In three studies for example,
metallic stents were compared with plastic endoprosthe-
ses.
33,38,39 The initial high costs made in the group with
metallic stents, were counterbalanced by the reduction in
the need for endoscopic re-interventions and/or re-
hospitalization. Therefore, the number of extra procedures
needed is a significant factor in the comparison of costs
and, based on our results, suggests a preference for the
PTBD group. The introduction of costs into the decision-
making process is of course, only justified when both
procedures under consideration have equal clinical benefit.
From a surgical point of view, preoperative PTBD may
have an additional advantage during exploration of the hilar
area of the liver. In the authors’ experience, the biliary tubes
help to define the bile ducts proximal of the tumor in the
operative field and to guide the parenchymal dissection at a
safe distance of the tumor. Also, when the resection has taken
place and the biliary ducts of the liver remnant are
anastomosed to a Roux-en-Y jejunal loop, the PTBD tubes
are shortened and used as transanastomotic drains to facilitate
healing of the hepaticojejunostomies. After a control cholan-
giography via the PTBD tubes at 3–6 weeks postoperatively,
the tubes are removed. In case of EBD, the stentsare removed
during resection and new transanastomotic biliary drains are
placed, usually in a retrograde fashion.
In conclusion, our results indicate that preoperative
percutaneous biliary drainage could outperform endoscopic
stent placement in patients with resectable HCCA,
showing fewer infectious complications resulting in
significantly less procedures. These results underline the
importance of further (randomized) studies to confirm
this point, which should be conducted in specialized
centers with experience in the preoperative work-up of
this relatively rare tumor.
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